Drug Shortage Report for LANSOPRAZOLE

Last updated on 2020-06-10 History
Report ID 90467
Drug Identification Number 02433028
Brand name LANSOPRAZOLE
Common or Proper name LANZOPRAZOLE
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-08-01
Actual start date 2019-09-09
Estimated end date 2020-07-10
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-06-10 French Compare
v12 2020-06-10 English Compare
v11 2020-03-10 French Compare
v10 2020-03-10 English Compare
v9 2019-12-24 French Compare
v8 2019-12-24 English Compare
v7 2019-11-15 French Compare
v6 2019-11-15 English Compare
v5 2019-09-12 French Compare
v4 2019-09-12 English Compare
v3 2019-08-02 English Compare
v2 2019-07-31 French Compare
v1 2019-07-31 English Compare

Showing 1 to 13 of 13